One hundred and eleven patients undergoing ketamine anaesthesia for therapeutic abortion were studied in a double-blind trial of the reversal of ketamine by physostigmine administered postoperatively. The results demonstrate that physostigmine does not shorten recovery time or reduce the occurrence of ketamine emergence phenomena such as hallucinations, restlessness and dreams. In fact, the recovery course was prolonged in patients given physostigmine immediately upon termination of anaesthesia as compared with controls. By contrast, when physostigmine was given 30 minutes after the last dose of ketamine, the recovery was not prolonged as compared with that of the placebo-treated controls. These findings suggest some synergism between the effects of ketamine and physostigmine and should discourage the use of physostigmine as a ketamine antidote.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF03006289DOI Listing

Publication Analysis

Top Keywords

ketamine physostigmine
12
reversal ketamine
8
ketamine
7
physostigmine
7
randomized evaluation
4
evaluation reversal
4
physostigmine eleven
4
eleven patients
4
patients undergoing
4
undergoing ketamine
4

Similar Publications

Pharmacological Prevention of Postoperative Delirium in Adults: A Review of Recent Literature.

Curr Neurol Neurosci Rep

December 2024

Department of Anesthesiology and Perioperative Medicine, Division of Cardiac and Vascular Anesthesia, Penn State Health, Hershey, PA, USA.

Article Synopsis
  • Postoperative delirium (POD) is a common issue for surgical patients that can result in cognitive problems, poorer outcomes, and higher healthcare costs, highlighting the need for strategies to reduce its occurrence.
  • Recent studies have investigated various medications, with dexmedetomidine showing the most potential in preventing POD, although its optimal dosing and timing remain unclear; other drugs like acetaminophen and melatonin also need further exploration.
  • Additionally, techniques like reducing anesthetic depth and using regional anesthesia are being considered, but they currently lack enough evidence to make strong recommendations, indicating a need for future research on these intervention strategies.
View Article and Find Full Text PDF

Prevailing hypotheses on the mechanisms of antidepressant action posit that antidepressants directly counteract deficiencies in major neurotransmitter signaling systems that underlie depression. The rapidly acting antidepressant ketamine has been postulated to correct excess glutamatergic signaling via glutamatergic antagonism leading to the rescue of neuronal structural deficits and reversal of behavioral symptoms. We studied this premise using systemic administration of the acetylcholinesterase inhibitor physostigmine, which has been shown to rapidly elicit a shorter-term period of depressed mood in humans via cholinergic mechanisms.

View Article and Find Full Text PDF

In the present study, we investigated the effects of microinjection of vitamin B into the hippocampus on the orofacial pain and memory impairments induced by scopolamine and orofacial pain. In ketamine-xylazine anesthetized rats, the right and left sides of the dorsal hippocampus (CA1) were implanted with two guide cannulas. Orofacial pain was induced by subcutaneous injection of formalin (1.

View Article and Find Full Text PDF

The use of bispectral index (BIS) for monitoring neuronal function under general anesthesia has been expanding in practice. However, the meanings of the values are not always clear and have been shown to be altered by such drugs as ketamine, ephedrine, and physostigmine. Presented here is a case of increasing BIS in response to noradrenergic beta receptor stimulation via the administration of isoproterenol while under general anesthesia.

View Article and Find Full Text PDF

Physostigmine is known to antagonize ketamine anesthesia. In this study, effects of physostigmine (0.1 mg kg(-1) i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!